CAP to launch new molecular proficiency testing program to prepare labs for measles resurgence
With the US at risk of losing its measles elimination status, CAP is advocating for laboratories to enhance their preparedness through a new MMRV molecular proficiency testing program. This initiative aims to mirror real-world workflows, improve virus detection, and distinguish vaccine reactions from true infections, starting August 24.
The College of American Pathologists (CAP) is advocating for clinical laboratories to prepare now for the United States to lose its measles elimination status. This could happen in November, according to a May Lancet article.
The CAP’s efforts include the development of their new Measles, Mumps, Rubella and Varicella-Zoster Virus (MMRV) Molecular Proficiency Testing program. The release of the MMRV program will make CAP “the only provider globally” to offer molecular proficiency testing that includes all four viruses and “closely mirrors real clinical laboratory workflows.” CAP advocates for molecular testing because it “detects the virus directly and can distinguish between vaccine-related reactions and true infection.”
The new program will be available starting August 24. It aims to help laboratories prepare for future outbreaks, manage testing demand, enhance testing accuracy and performance, and deliver timely results.
